The effects of mesenchymal stem cells in craniofacial tissue engineering

Current Stem Cell Research and Therapy

Volumn 9, Issue 3, 2014, Pages 280-289

  Zhang, Lin ^a,b   Feng, Ge ^a,b   Wei, Xing ^a,b   Huang, Lan ^a,b   Ren, Aishu ^a,b   Dong, Ni ^a,b   Wang, Huaqiao ^a,b   Huang, Qianqian ^a,b   Zhang, Yi ^a,b   Deng, Feng ^a,b  

^a Chongqing Key Laboratory for Oral Diseases and Biomedical Sciences   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Adipose stem cells; Craniofacial reconstruction; Mesenchymal stem cells; Tissue engineering

Indexed keywords

ANIMALS; CELL DIFFERENTIATION; CRANIOFACIAL ABNORMALITIES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; TISSUE ENGINEERING;

EID: 84904514750     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X09666140213204202     Document Type: Review

References (104)

1. Weiss J, Kotelchuck M, Grosse SD, et al. Hospital use and associ-ated costs of children aged zero-to-two years with craniofacial malformations in Massachusetts. Birth Defects Res A Clin Mol Teratol 2009; 85(11): 925-34.
2. Lin Y. Potential application of mesenchymal stem cells in craniofa-cial reconstruction. Curr Stem Cell Res Ther 2014; 9(3): 148.
3. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursorsin normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4(5): 267-74.
4. Usas A, Huard J. Muscle-derived stem cells for tissue engineeringand regenerative therapy. Biomaterials 2007; 28(36): 5401-6.
5. Mara CS, Sartori AR, Duarte AS, Andrade AL, Pedro MA, Coim-bra IB. Periosteum as a source of mesenchymal stem cells: the effects of TGF-beta3 on chondrogenesis. Clinics (Sao Paulo) 2011; 66(3): 487-92.
6. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells inhuman umbilical cord blood. Br J Haematol 2000; 109(1): 235-42.
7. Kim J, Park JC, Kim SH, et al. Treatment of FGF-2 on stem cellsfrom inflamed dental pulp tissue from human deciduous teeth. Oral Dis 2014; 20(2): 191-204.
8. Wang X, Sha XJ, Li GH, et al. Comparative characterization ofstem cells from human exfoliated deciduous teeth and dental pulp stem cells. Arch Oral Biol 2012; 57(9): 1231-40.
9. Kerkis I, Caplan AI. Stem cells in dental pulp of deciduous teeth. Tissue Eng Part B Rev 2012; 18(2): 129-38.
10. Rodriguez AM, Elabd C, Amri EZ, Ailhaud G, Dani C. The humanadipose tissue is a source of multipotent stem cells. Biochimie 2005; 87(1): 125-8.
11. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from humanadipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7(2): 211-28.
12. Mesenchymal stem cells in the treatment of chronic liver disease--from experiment to clinical practice. Eksp Klin Gastroenterol 2012; (6): 13-9.
13. Shi M, Zhang Z, Xu R, et al. Human mesenchymal stem cell trans-fusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med 2012; 1(10): 725-31.
14. Narita T, Shintani Y, Ikebe C, et al. The Use of Scaffold-free CellSheet Technique to Refine Mesenchymal Stromal Cell-based Therapy for Heart Failure. Mol Ther 2013; 21(4): 860-7.
15. Fiumana E, Pasquinelli G, Foroni L, et al. Localization of mesen-chymal stem cells grafted with a hyaluronan-based scaffold in the infarcted heart. J Surg Res 2013; 179(1): e21-9.
16. Donega V, van Velthoven CT, Nijboer CH, et al. Intranasal mesen-chymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PLOS ONE 2013; 8(1): e51253.
17. Morigi M, Benigni A. Mesenchymal stem cells and kidney repair. Nephrol Dial Transplant 2013; 28(4): 788-93.
18. Wise AF, Ricardo SD. Mesenchymal stem cells in kidney inflam-mation and repair. Nephrology (Carlton) 2012; 17(1): 1-10.
19. Touboul C, Lis R, Al FH, et al. Mesenchymal stem cells enhanceovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model. J Transl Med 2013; 11: 28.
20. Lis R, Touboul C, Mirshahi P, et al. Tumor associated mesenchy-mal stem cells protects ovarian cancer cells from hyperthermia through CXCL12. Int J Cancer 2011; 128(3): 715-25.
21. Caplan AI. Review: mesenchymal stem cells: cell-based recon-structive therapy in orthopedics. Tissue Eng 2005; 11(7-8): 1198-211.
22. Schmitt A, van Griensven M, Imhoff AB, Buchmann S. Applica-tion of stem cells in orthopedics. Stem Cells Int 2012; 2012: 394962.
23. Caplan AI. New era of cell-based orthopedic therapies. Tissue EngPart B Rev 2009; 15(2): 195-200.
24. Dimitriou R, Jones E, McGonagle D, Giannoudis PV. Bone regeneration: current concepts and future directions. BMC Med 2011; 9:66.
25. Wang F, Yu M, Yan X, et al. Gingiva-derived mesenchymal stemcell-mediated therapeutic approach for bone tissue regeneration. Stem Cells Dev 2011; 20(12): 2093-102.
26. Khojasteh A, Behnia H, Hosseini FS, Dehghan MM, Abbasnia P, Abbas FM. The effect of PCL-TCP scaffold loaded with mesenchymal stem cells on vertical bone augmentation in dog mandible: a preliminary report. J Biomed Mater Res B Appl Biomater 2013; 101(5): 848-54.
27. Inukai T, Katagiri W, Yoshimi R, et al. Novel application of stemcell-derived factors for periodontal regeneration. Biochem Biophys Res Commun 2013; 430(2): 763-8.
28. Castro-Govea Y, Cervantes-Kardasch VH, Borrego-Soto G, et al. Human bone morphogenetic protein 2-transduced mesenchymal stem cells improve bone regeneration in a model of mandible distraction surgery. J Craniofac Surg. 2012. 23(2): 392-6.
29. Stephan SJ, Tholpady SS, Gross B, et al. Injectable tissue-engineered bone repair of a rat calvarial defect. Laryngoscope 2010; 120(5): 895-901.
30. Chung VH, Chen AY, Jeng LB, Kwan CC, Cheng SH, Chang SC. Engineered autologous bone marrow mesenchymal stem cells: alternative to cleft alveolar bone graft surgery. J Craniofac Surg 2012; 23(5): 1558-63.
31. Stockmann P, Park J, von WC, et al. Guided bone regeneration inpig calvarial bone defects using autologous mesenchymal stem/progenitor cells a comparison of different tissue sources. J Craniomaxillofac Surg 2012; 40(4): 310-20.
32. Monteiro BS, Argolo-Neto NM, Nardi NB, et al. Treatment ofcritical defects produced in calvaria of mice with mesenchymal stem cells. An Acad Bras Cienc 2012; 84(3): 841-51.
33. Quarto R, Mastrogiacomo M, Cancedda R, et al. Repair of largebone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001; 344(5): 385-6.
34. Meijer GJ, de Bruijn JD, Koole R, van Blitterswijk CA. Cell basedbone tissue engineering in jaw defects. Biomaterials 2008; 29(21): 3053-61.
35. Lendeckel S, Jodicke A, Christophis P, et al. Autologous stem cells(adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg 2004; 32(6): 370-3.
36. Mesimaki K, Lindroos B, Tornwall J, et al. Novel maxillary recon-struction with ectopic bone formation by GMP adipose stem cells. Int J Oral Maxillofac Surg 2009; 38(3): 201-9.
37. Sandor GK. Tissue engineering of bone: Clinical observations withadipose-derived stem cells, resorbable scaffolds, and growth factors. Ann Maxillofac Surg 2012; 2(1): 8-11.
38. Sandor GK, Tuovinen VJ, Wolff J, et al. Adipose Stem Cell Tis-sue-Engineered Construct Used to Treat Large Anterior Mandibular Defect: A Case Report and Review of the Clinical Application of Good Manufacturing Practice-Level Adipose Stem Cells for Bone Regeneration. J Oral Maxillofac Surg 2013; 71(5): 938-950.
39. Thesleff T, Lehtimaki K, Niskakangas T, et al. Cranioplasty withadipose-derived stem cells and biomaterial: a novel method for cranial reconstruction. Neurosurgery 2011; 68(6): 1535-40.
40. Behnia H, Khojasteh A, Soleimani M, Tehranchi A, Atashi A. Repair of alveolar cleft defect with mesenchymal stem cells and platelet derived growth factors: a preliminary report. J Craniomaxillofac Surg 2012; 40(1): 2-7.
41. Sandor GK. Tissue engineering of bone: Clinical observations withadipose-derived stem cells, resorbable scaffolds, and growth factors. Ann Maxillofac Surg 2012; 2(1): 8-11.
42. Sandor GK, Tuovinen VJ, Wolff J, et al. Adipose stem cell tissue-engineered construct used to treat large anterior mandibular defect: a case report and review of the clinical application of good manufacturing practice-level adipose stem cells for bone regeneration. J Oral Maxillofac Surg 2013; 71(5): 938-50.
43. Sharma P, Maffulli N. Tendon injury and tendinopathy: healingand repair. J Bone Joint Surg Am 2005; 87(1): 187-202.
44. Butler DL, Juncosa N, Dressler MR. Functional efficacy of tendonrepair processes. Annu Rev Biomed Eng 2004; 6: 303-29.
45. Schu S, Nosov M, O'Flynn L, et al. Immunogenicity of allogeneicmesenchymal stem cells. J Cell Mol Med 2012; 16(9): 2094-103.
46. Duffy MM, Pindjakova J, Hanley SA, et al. Mesenchymal stem cellinhibition of T-helper 17 celldifferentiation is triggered by cellcell contact and mediated by prostaglandin E2 via the EP4 receptor. Eur J Immunol 2011; 41(10): 2840-51.
47. Lee JY, Zhou Z, Taub PJ, et al. BMP-12 treatment of adult mesen-chymal stem cells in vitro augments tendon-like tissue formation and defect repair in vivo. PLOS ONE 2011; 6(3): e17531.
48. Shearn JT, Juncosa-Melvin N, Boivin GP, et al. Mechanical stimu-lation of tendon tissue engineered constructs: effects on construct stiffness, repair biomechanics, and their correlation. J Biomech Eng 2007; 129(6): 848-54.
49. Butler DL, Juncosa-Melvin N, Boivin GP, et al. Functional tissueengineering for tendon repair: A multidisciplinary strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulation. J Orthop Res 2008; 26(1): 1-9.
50. Chen X, Yin Z, Chen JL, et al. Force and scleraxis synergisticallypromote the commitment of human ES cells derived MSCs to tenocytes. Sci Rep 2012; 2: 977.
51. Crovace A, Lacitignola L, Rossi G, Francioso E. Histological andimmunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon. Vet Med Int 2010; 2010: 250978.
52. Smith RK, Werling NJ, Dakin SG, Alam R, Goodship AE, Dudhia J. Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy. PLOS ONE 2013; 8(9): e75697.
53. Lange-Consiglio A, Tassan S, Corradetti B, et al. Investigating theefficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries. Cytotherapy 2013; 15(8): 1011-20.
54. Wongtriratanachai P, Pruksakorn D, Pothacharoen P, et al. Autolo-gous chondrocyte implantation for cartilage injury treatment in Chiang Mai University Hospital: a case report. J Med Assoc Thai. 2013. 96(11): 1518-22.
55. Lee KB, Wang VT, Chan YH, Hui JH. A novel, minimally-invasive technique of cartilage repair in the human knee using ar-throscopic microfracture and injections of mesenchymal stem cells and hyaluronic acid--a prospective comparative study on safety and short-term efficacy. Ann Acad Med Singapore. 2012; 41(11): 511-7.
56. Ciocca L, Donati D, Ragazzini S, et al. Mesenchymal stem cellsand platelet gel improve bone deposition within CAD-CAM custom-made ceramic HA scaffolds for condyle substitution. Biomed Res Int 2013; 2013: 549762.
57. Nam H, Karunanithi P, Loo WC, et al. The effects of staged intra-articular injection of cultured autologous mesenchymal stromal cells on the repair of damaged cartilage: a pilot study in caprine model. Arthritis Res Ther 2013; 15(5): R129.
58. Qi Y, Du Y, Li W, Dai X, Zhao T, Yan W. Cartilage repair usingmesenchymal stem cell (MSC) sheet and MSCs-loaded bilayer PLGA scaffold in a rabbit model. Knee Surg Sports Traumatol Arthrosc 2012.
59. Nakamura T, Sekiya I, Muneta T, Kobayashi E. Bone and Carti-lage Diseases and Regeneration. Articular cartilage regenerative therapy with synovial mesenchymal stem cells in a pig model. Clin Calcium 2013; 23(12): 1741-9.
60. Nejadnik H, Hui JH, Feng CEP, Tai BC, Lee EH. Autologous bonemarrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med 2010; 38(6): 1110-6.
61. Wong KL, Lee KB, Tai BC, Law P, Lee EH, Hui JH. InjectableCultured Bone Marrow-Derived Mesenchymal Stem Cells in Varus Knees With Cartilage Defects Undergoing High Tibial Osteotomy: A Prospective, Randomized Controlled Clinical Trial With 2 Years' Follow-up. Arthroscopy 2013; 29(12): 2020-8.
62. Davatchi F, Abdollahi BS, Mohyeddin M, Shahram F, Nikbin B.Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis 2011; 14(2): 211-5.
63. Orozco L, Munar A, Soler R, et al. Treatment of knee osteoarthritiswith autologous mesenchymal stem cells: a pilot study. Transplantation 2013. 95(12): 1535-41.
64. Farrell MJ, Fisher MB, Huang AH, Shin JI, Farrell KM, Mauck RL. Functional properties of bone marrow-derived MSC-based engineered cartilage are unstable with very long-term in vitro culture. J Biomech 2013 Oct 22. pii: S0021-9290(13)00484-3.
65. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repairand regeneration. Nature 2008; 453(7193): 314-21.
66. Hocking AM, Gibran NS. Mesenchymal stem cells: paracrine sig-naling and differentiation during cutaneous wound repair. Exp Cell Res 2010; 316(14): 2213-9.
67. Huang S, Lu G, Wu Y, et al. Mesenchymal stem cells delivered ina microsphere-based engineered skin contribute to cutaneous wound healing and sweat gland repair. J Dermatol Sci 2012; 66(1): 29-36.
68. Kim JW, Lee JH, Lyoo YS, Jung DI, Park HM. The effects oftopical mesenchymal stem cell transplantation in canine experimental cutaneous wounds. Vet Dermatol 2013; 24(2): 242-e53.
69. Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cellsenhance wound healing through differentiation and angiogenesis. Stem Cells 2007; 25(10): 2648-59.
70. Stoff A, Rivera AA, Sanjib BN, et al. Promotion of incisionalwound repair by human mesenchymal stem cell transplantation. Exp Dermatol 2009; 18(4): 362-9.
71. Xu Y, Shi Y, Ding S. A chemical approach to stem-cell biologyand regenerative medicine. Nature 2008; 453(7193): 338-44.
72. Chang EI, Bonillas RG, El-ftesi S, et al. Tissue engineering usingautologous microcirculatory beds as vascularized bioscaffolds. FASEB J 2009; 23(3): 906-15.
73. Ghajar CM, Blevins KS, Hughes CC, George SC, Putnam AJ. Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation. Tissue Eng 2006; 12(10): 2875-88.
74. Ghajar CM, Kachgal S, Kniazeva E, et al. Mesenchymal cellsstimulate capillary morphogenesis via distinct proteolytic mechanisms. Exp Cell Res 2010; 316(5): 813-25.
75. Burns JS, Kristiansen M, Kristensen LP, et al. Decellularized ma-trix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interaction. PLOS ONE 2011; 6(7): e21888.
76. Roubelakis MG, Tsaknakis G, Pappa KI, Anagnou NP, Watt SM.Spindle shaped human mesenchymal stem/stromal cells from am-niotic fluid promote neovascularization. PLOS ONE 2013; 8(1): e54747.
77. Zigdon-Giladi H, Bick T, Lewinson D, Machtei EE. Co-transplantation of endothelial progenitor cells and mesenchymal stem cells promote neovascularization and bone regeneration. Clin Implant Dent Relat Res 2013 Jul 12 [Epub ahead of print].
78. Mestak O, Matouskova E, Spurkova Z, et al. Mesenchymal stemcells seeded on cross-linked and noncross-linked acellular porcine dermal scaffolds for long-term full-thickness hernia repair in a small animal model. Artif Organs 2013 Dec 4. [Epub ahead of print].
79. Bhang SH, Lee S, Shin JY, Lee TJ, Kim BS. Transplantation ofcord blood mesenchymal stem cells as spheroids enhances vascularization. Tissue Eng Part A 2012; 18(19-20): 2138-47.
80. Seebach C, Henrich D, Wilhelm K, Barker JH, Marzi I. Endothelialprogenitor cells improve directly and indirectly early vascularization of mesenchymal stem cell-driven bone regeneration in a critical bone defect in rats. Cell Transplant 2012; 21(8): 1667-77.
81. Chen DY, Wei HJ, Lin KJ, et al. Three-dimensional cell aggregatescomposed of HUVECs and cbMSCs for therapeutic neovascularization in a mouse model of hindlimb ischemia. Biomaterials 2013; 34(8): 1995-2004.
82. Laschke MW, Schank TE, Scheuer C, et al. Three-dimensionalspheroids of adipose-derived mesenchymal stem cells are potent initiators of blood vessel formation in porous polyurethane scaffolds. Acta Biomater 2013; 9(6): 6876-84.
83. Sanchez-Lara PA, Warburton D. Impact of stem cells in craniofa-cial regenerative medicine. Front Physiol 2012; 3: 188.
84. Chatzivasileiou K, Lux CA, Steinhoff G, Lang H. Dental follicleprogenitor cells responses to Porphyromonas gingivalis LPS. J Cell Mol Med 2013; 17(6): 766-73.
85. Sonoyama W, Liu Y, Fang D, et al. Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLOS ONE 2006; 1: e79.
86. Yang ZH, Zhang XJ, Dang NN, et al. Apical tooth germ cell-conditioned medium enhances the differentiation of periodontal ligament stem cells into cementum/periodontal ligament-like tissues. J Periodontal Res 2009; 44(2): 199-210.
87. Cordeiro MM, Dong Z, Kaneko T, et al. Dental pulp tissue engi-neering with stem cells from exfoliated deciduous teeth. J Endod 2008; 34(8): 962-9.
88. Sakai VT, Zhang Z, Dong Z, et al. SHED differentiate into func-tional odontoblasts and endothelium. J Dent Res 2010; 89(8): 791-6.
89. Wei F, Song T, Ding G, et al. Functional tooth restoration by allo-geneic mesenchymal stem cell-based bio-root regeneration in swine. Stem Cells Dev 2013; 22(12): 1752-62.
90. Navarro M, Michiardi A, Castano O, Planell JA. Biomaterials inorthopaedics. J R Soc Interface 2008; 5(27): 1137-58.
91. Eldesoqi K, Henrich D, El-Kady AM, et al. Safety evaluation of abioglass-polylactic Acid composite scaffold seeded with progenitor cells in a rat skull critical-size bone defect. PLOS ONE 2014; 9(2): e87642.
92. Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): roleas guardians of inflammation. Mol Ther 2012; 20(1): 14-20.
93. Ortiz LA, Dutreil M, Fattman C, et al. Interleukin 1 receptor an-tagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 2007; 104(26): 11002-7.
94. Roddy GW, Oh JY, Lee RH, et al. Action at a distance: systemi-cally administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-alpha stimulated gene/protein 6. Stem Cells 2011; 29(10): 1572-9.
95. Nemeth K, Leelahavanichkul A, Yuen PS, et al. Bone marrowstromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15(1): 42-9.
96. Zou JP, Huang S, Peng Y, et al. Mesenchymal stemcells/multipotent mesenchymal stromal cells (MSCs): potential role in healing cutaneous chronic wounds. Int J Low Extrem Wounds 2012; 11(4): 244-53.
97. Hocking AM, Gibran NS. Mesenchymal stem cells: paracrine sig-naling and differentiation during cutaneous wound repair. Exp Cell Res 2010; 316(14): 2213-9.
98. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. Invitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998; 238(1): 265-72.
99. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dy-namic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001; 169(1): 12-20.
100. Gao J, Dennis JE, Solchaga LA, Awadallah AS, Goldberg VM, Caplan AI. Tissue-engineered fabrication of an osteochondral composite graft using rat bone marrow-derived mesenchymal stem cells. Tissue Eng 2001; 7(4): 363-71.
101. Lau K, Paus R, Tiede S, Day P, Bayat A. Exploring the role ofstem cells in cutaneous wound healing. Exp Dermatol 2009; 18(11): 921-33.
102. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms inadult stem cell signaling and therapy. Circ Res 2008; 103(11): 1204-19.
103. Chen L, Tredget EE, Wu PY, Wu Y. Paracrine factors of mesen-chymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLOS ONE 2008; 3(4): e1886.
104. Spees JL, Olson SD, Ylostalo J, et al. Differentiation, cell fusion,and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci USA 2003; 100(5): 2397-402.